Para citar este trabalho use um dos padrões abaixo:
Leishmaniasis, classified by the WHO as a neglected tropical disease, affects approximately 1.3 million people annually and places 310 million individuals at risk of infection. Current therapies are associated with several adverse effects and contribute to the emergence of drug-resistant strains, highlighting the urgent need for alternative therapeutic approaches. Metalcomplexes, compounds containing a metal center capable of coordinating with organic ligands, offer advantages over conventional drugs by enabling multiple geometries and interactions. A zinc (II) complex was tested in vitro against Leishmania amazonensis promastigotes resulting in an IC50 of 0.98 to 1.8 µM after 24 and 120 h, respectively. Treated parasites presented ultrastructural alterations such as endoplasmic reticulum enlagement, plasma membrane blebbing and cytoplasm disintegration compatible with necrosis. Metalocomplex caused low toxicity to LLC-MK2 host cell line. In addition, we evaluated the in vivo effect of this metalocomplex associated with a biocurative. Lesions were induced in BALB/c mice (CEUA/UENF No. 486) and treated. After 40 days of treatment lesion size reduced, with the skin displaying epidermis, dermis, and hypodermis, indicating advanced regeneration compared with the control group. In vitro, the zinc (II) metallocomplex showed significant antileishmanial activity against Leishmania amazonensis promastigotes, with low toxicity toward LLC-MK2 host cells. In vivo, its association with the biocurative promoted lesion size reduction and advanced tissue regeneration after 40 days of treatment. These findings support the potential of this metalocomplex, particularly in combination with the biocurative, as a promising therapeutic strategy against cutaneous leishmaniasis.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo